Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Lee, Hyunju; Stephen Hodi, F.; Giobbie‐Hurder, Anita; A. Ott, Patrick; I. Buchbinder, Elizabeth; Haq, Rizwan; M. Tolaney, Sara; Barroso‐Sousa, Romualdo; Zhang, Kevin; Donahue, Hilary; Davis, Meredith; Gargano, Maria; M. Kelley, Kristina; S. Carroll, Rona; B. Kaiser, Ursula; Min, Le

doi:10.1158/2326-6066.cir-17-0208

Public

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Published in Cancer Immunology Research • Oct 28, 2017

Authors:

Hyunju Lee

F. Stephen Hodi

Anita Giobbie‐Hurder

Abstract

Abstract Thyroid disorders have emerged as one of the most common immune-related adverse events associated with anti–PD-1 monotherapy or combination anti–PD-1 and anti–CTLA-4 therapy. This study characterizes and compares the evolution of monotherapy and combination therapy-related thyroid disorders...

Subject

Medicine

Thyroiditis

Combination therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!